Brief: Shareholders Oppose Plan Of Arrangement Between Emerald Health Therapeutics And Skye Biosciences Inc
04/08/2022 11:06
Aug 4 (Reuters) - Emerald Health Therapeutics Inc EMH.CD :
* GROUP OF SHAREHOLDERS OPPOSE PLAN OF ARRANGEMENT BETWEEN
EMERALD
HEALTH THERAPEUTICS AND SKYE BIOSCIENCES INC.
* OPPOSING SHAREHOLDERS OF EMERALD HEALTH THERAPEUTICS SAY
THEY
OPPOSE ANNOUNCED PLAN OF ARRANGEMENT BETWEEN EMERALD AND SKYE
BIOSCIENCES INC
Source text for Eikon: ID:nCNWkHyfPa
Further company coverage: EMH.CD
Recent news on Skye Bioscience
See all newsRCS - Redx Pharma Limited - Redx to Present Poster on RXC008 at UEG Week
RCS - Redx Pharma Limited - Redx Announces ROCKETEER Phase 2 Trial for RXC008
Brief: Skye Bioscience Says John Sharp Resigns As CFO - SEC Filing
Brief: Skye Bioscience - Enters $22 Million Securities Purchase Agreement With Redmile Biopharma Investments Iii - SEC Filing
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM